miR-200c, a member of the miR-200 family, inhibits intratumoral angiogenesis in ovarian cancer by downregulating the expression of interleukin (IL)-8 and C-X-C motif chemokine ligand 1 (CXCL1) [19]. This evidence concerns the gene CXCL1 and ovarian cancer.